Tumor cells express factors that inhibit an anti-tumor immune response, such as programmed cell death 1 ligand 1 (PD-L1), indoleamine 2,3-dioxygenase (IDO), IL-10 and transforming growth factor-β (TGF-β). This evidence concerns the gene TGFB1 and neoplasm.